PetLife Pharmaceuticals, Inc. Accumulated Other Comprehensive Income
PetLife Pharmaceuticals, Inc. had Accumulated Other Comprehensive Income of $3.44 million as of 2015-08-31, per its 10-K/A filed 2016-01-06.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2016-01-06
- 2015-08-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $3.44M; Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed $3.45M.
- 2014-08-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.51M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2015-08-31 | $3.44M 10-K/A · filed 2016-01-06 | $3.45M 10-K · filed 2016-01-05 |
| 2014-08-31 | $1.51M 10-K · filed 2015-12-31 |